Market Overview:
The global computer-aided drug discovery (CADD) services market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The market was valued at US$ 2,362.5 million in 2017 and is projected to reach US$ 6,711.9 million by 2030. The growth of the market can be attributed to the increasing demand for computer-aided drug discovery services from pharmaceutical and biotechnology companies, academic and research institutes, and others across the globe. The global computer-aided drug discovery (CADD) services market can be segmented on the basis of type into virtual screening, molecular docking, molecular modeling, scaffold hopping, and others. Virtual screening accounted for the largest share of the global CADD services market in 2017 owing to its ability to identify potential leads from large databases of compounds within a short time frame as compared with traditional methods such as wet lab experiments or high throughput screening (HTS).
 Services Industry Outlook.svg)
Product Definition:
Computer-Aided Drug Discovery (CADD) Services are a set of tools used to help identify potential new drugs and optimize their development. They can include software for designing molecules, predicting their properties, and screening them against biological targets. CADD services can be important for reducing the time and cost of drug discovery.
Virtual Screening:
Virtual screening is a computer-aided drug discovery technique that involves the visualization of molecules or small segments of molecules in 3D space. The technique helps in the identification and prioritization of high-risk targets for chemical compounds, thus reducing human exposure to low-risk compounds during clinical trials.
The global CADD services market was valued at USD 2,64 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period.
Molecular Docking:
Molecular docking is a computer-aided drug designing process that involves the binding and insertion of ligands into the target proteins. The molecular docking procedure is carried out by several steps including identification of appropriate ligand, selection of an appropriate protein structure, preparation of suitable solutions for dockings, and finally performing dockings on these solutions to find out the best fit.
Application Insights:
The others application segment held the largest share of over 50.0% in 2017. The growth can be attributed to the increasing demand for CADD services from other applications such as chemical synthesis, bioinformatics and biopharmaceutical development. In addition, factors such as growing R&D expenditure by companies and government initiatives supporting academic research are also responsible for driving the market growth in this segment during future years.
Pharmaceutical or biotechnology companies accounted for a significant share in 2017 owing to extensive usage of computer-aided drug design (CADD) services by these companies to develop novel drugs with fewer side effects and lower costs associated with their production & development process.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, increased funding for R&D activities, and high adoption rate of new technologies. Moreover, increasing demand for novel therapeutics and growing need to reduce drug development time are expected to drive this regional market further.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as rising healthcare spending by countries like China & India coupled with government support for innovation through FDI policies or investments in CSA research centers that focus on cancer & chronic diseases. These factors are expected favorably impact overall CAD services demand in this region during the forecast period from 2018 To 2030 (see figure below).
The Latin American region is also likely have significant growth opportunities due its proximity with Asian countries offering low-cost labor force and infrastructure facilities which makes it an attractive outsourcing destination particularly for clinical trials involving patients from developed economies such as U.S.
Growth Factors:
- Increasing demand for novel drugs and therapies to treat various diseases
- Rising prevalence of chronic diseases and disorders
- Growing number of drug discovery collaborations between pharmaceutical companies and academic institutions
- Proliferation of personalized medicine and companion diagnostics
- Advances in informatics, computational biology, and cheminformatics
Scope Of The Report
Report Attributes
Report Details
Report Title
Computer-Aided Drug Discovery (CADD) Services Market Research Report
By Type
Virtual Screening, Molecular Docking, Molecular Modeling, Scaffold Hopping, Others
By Application
Pharmaceutical or Biotechnology Companies, Academic or Research Institutes, Others
By Companies
AMRI, Charles River, Schrödinger, Evotec, Bayers, GVK Biosciences, AstraZeneca, BioDuro, BOC Sciences, Aris Pharmaceuticals, ChemDiv, RTI International, XRQTC, Pharmaron
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
176
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Computer-Aided Drug Discovery (CADD) Services Market Report Segments:
The global Computer-Aided Drug Discovery (CADD) Services market is segmented on the basis of:
Types
Virtual Screening, Molecular Docking, Molecular Modeling, Scaffold Hopping, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical or Biotechnology Companies, Academic or Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AMRI
- Charles River
- Schrödinger
- Evotec
- Bayers
- GVK Biosciences
- AstraZeneca
- BioDuro
- BOC Sciences
- Aris Pharmaceuticals
- ChemDiv
- RTI International
- XRQTC
- Pharmaron
 Services Market Overview.svg)
Highlights of The Computer-Aided Drug Discovery (CADD) Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Virtual Screening
- Molecular Docking
- Molecular Modeling
- Scaffold Hopping
- Others
- By Application:
- Pharmaceutical or Biotechnology Companies
- Academic or Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Computer-Aided Drug Discovery (CADD) Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Services Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Computer-Aided Drug Discovery (CADD) Services are a type of technology that help researchers identify potential drug candidates by using computer algorithms to analyze large data sets. CADD can be used in a variety of research areas, including cancer, infectious diseases, and Alzheimer's disease.
Some of the key players operating in the computer-aided drug discovery (cadd) services market are AMRI, Charles River, Schr¶dinger, Evotec, Bayers, GVK Biosciences, AstraZeneca, BioDuro, BOC Sciences, Aris Pharmaceuticals, ChemDiv, RTI International, XRQTC, Pharmaron.
The computer-aided drug discovery (cadd) services market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Computer-Aided Drug Discovery (CADD) Services Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Computer-Aided Drug Discovery (CADD) Services Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Computer-Aided Drug Discovery (CADD) Services Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Computer-Aided Drug Discovery (CADD) Services Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Computer-Aided Drug Discovery (CADD) Services Market Size & Forecast, 2018-2028
4.5.1 Computer-Aided Drug Discovery (CADD) Services Market Size and Y-o-Y Growth
4.5.2 Computer-Aided Drug Discovery (CADD) Services Market Absolute $ Opportunity
Chapter 5 Global Computer-Aided Drug Discovery (CADD) Services Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Computer-Aided Drug Discovery (CADD) Services Market Size Forecast by Type
5.2.1 Virtual Screening
5.2.2 Molecular Docking
5.2.3 Molecular Modeling
5.2.4 Scaffold Hopping
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Computer-Aided Drug Discovery (CADD) Services Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Computer-Aided Drug Discovery (CADD) Services Market Size Forecast by Applications
6.2.1 Pharmaceutical or Biotechnology Companies
6.2.2 Academic or Research Institutes
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Computer-Aided Drug Discovery (CADD) Services Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Computer-Aided Drug Discovery (CADD) Services Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Computer-Aided Drug Discovery (CADD) Services Analysis and Forecast
9.1 Introduction
9.2 North America Computer-Aided Drug Discovery (CADD) Services Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Computer-Aided Drug Discovery (CADD) Services Market Size Forecast by Type
9.6.1 Virtual Screening
9.6.2 Molecular Docking
9.6.3 Molecular Modeling
9.6.4 Scaffold Hopping
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Computer-Aided Drug Discovery (CADD) Services Market Size Forecast by Applications
9.10.1 Pharmaceutical or Biotechnology Companies
9.10.2 Academic or Research Institutes
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Computer-Aided Drug Discovery (CADD) Services Analysis and Forecast
10.1 Introduction
10.2 Europe Computer-Aided Drug Discovery (CADD) Services Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Computer-Aided Drug Discovery (CADD) Services Market Size Forecast by Type
10.6.1 Virtual Screening
10.6.2 Molecular Docking
10.6.3 Molecular Modeling
10.6.4 Scaffold Hopping
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Computer-Aided Drug Discovery (CADD) Services Market Size Forecast by Applications
10.10.1 Pharmaceutical or Biotechnology Companies
10.10.2 Academic or Research Institutes
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Computer-Aided Drug Discovery (CADD) Services Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Computer-Aided Drug Discovery (CADD) Services Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Computer-Aided Drug Discovery (CADD) Services Market Size Forecast by Type
11.6.1 Virtual Screening
11.6.2 Molecular Docking
11.6.3 Molecular Modeling
11.6.4 Scaffold Hopping
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Computer-Aided Drug Discovery (CADD) Services Market Size Forecast by Applications
11.10.1 Pharmaceutical or Biotechnology Companies
11.10.2 Academic or Research Institutes
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Computer-Aided Drug Discovery (CADD) Services Analysis and Forecast
12.1 Introduction
12.2 Latin America Computer-Aided Drug Discovery (CADD) Services Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Computer-Aided Drug Discovery (CADD) Services Market Size Forecast by Type
12.6.1 Virtual Screening
12.6.2 Molecular Docking
12.6.3 Molecular Modeling
12.6.4 Scaffold Hopping
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Computer-Aided Drug Discovery (CADD) Services Market Size Forecast by Applications
12.10.1 Pharmaceutical or Biotechnology Companies
12.10.2 Academic or Research Institutes
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Computer-Aided Drug Discovery (CADD) Services Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Computer-Aided Drug Discovery (CADD) Services Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Computer-Aided Drug Discovery (CADD) Services Market Size Forecast by Type
13.6.1 Virtual Screening
13.6.2 Molecular Docking
13.6.3 Molecular Modeling
13.6.4 Scaffold Hopping
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Computer-Aided Drug Discovery (CADD) Services Market Size Forecast by Applications
13.10.1 Pharmaceutical or Biotechnology Companies
13.10.2 Academic or Research Institutes
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Computer-Aided Drug Discovery (CADD) Services Market: Competitive Dashboard
14.2 Global Computer-Aided Drug Discovery (CADD) Services Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AMRI
14.3.2 Charles River
14.3.3 Schrödinger
14.3.4 Evotec
14.3.5 Bayers
14.3.6 GVK Biosciences
14.3.7 AstraZeneca
14.3.8 BioDuro
14.3.9 BOC Sciences
14.3.10 Aris Pharmaceuticals
14.3.11 ChemDiv
14.3.12 RTI International
14.3.13 XRQTC
14.3.14 Pharmaron
